![]() |
市場調查報告書
商品編碼
2009276
水凝膠敷料市場規模、佔有率、趨勢和預測:按產品、材料、應用、最終用戶和地區分類,2026-2034年Hydrogel Dressing Market Size, Share, Trends and Forecast by Product, Material, Application, End User, and Region, 2026-2034 |
||||||
2025年全球水凝膠敷料市場規模為4.969億美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以4.33%的複合年成長率成長,到2034年達到7.363億美元。目前,北美市場主導地位,預計2025年將佔43.5%的市場。隨著糖尿病、肥胖症和血管疾病的日益普遍,糖尿病足潰瘍、靜脈性腿部潰瘍和壓瘡的發生率也不斷上升。此外,技術創新和產品研發也不斷改進水凝膠的配方。同時,醫療專業人員對患者舒適度和傷口管理成本效益的關注也推動了水凝膠敷料市場佔有率的擴大。
隨著醫療專業人員逐步採用創新創傷護理方案,水凝膠敷料市場正經歷穩定成長。慢性傷口、燒傷、糖尿病潰瘍和壓瘡的日益增多,推動了對更有效、以患者為中心的治療方法的需求。水凝膠敷料因其能夠維持傷口濕潤環境、緩解疼痛和促進癒合等優勢,正在擴大市場規模。該領域的技術不斷進步,製造商正在開發具有卓越吸收性、抗菌性和生物相容性的突破性產品。各公司持續加大研發投入,與醫療機構的合作也推動了產品創新。人們對先進創傷護理療法的認知不斷提高,尤其是在醫療體係不斷完善的開發中國家,這進一步促進了市場成長。
美國水凝膠敷料市場正穩步成長,這主要得益於醫院、診所和居家醫療機構對先進創傷護理產品需求的不斷成長。糖尿病和肥胖等慢性疾病的日益普遍導致糖尿病足潰瘍和壓瘡的發生率上升,進一步推動了市場發展。醫療保健專業人員擴大採用這些產品來維持傷口濕潤環境、促進癒合並提高患者舒適度。該行業正經歷持續創新,製造商不斷推出具有增強抗菌性能、吸收性和適用性的水凝膠敷料。不斷擴大的研發活動以及醫療設備製造商與醫療保健機構之間的策略合作正在推動產品進步。此外,醫療保健專業人員和患者對先進創傷護理解決方案益處的認知不斷提高,也增強了市場實力。 2024年,美國食品藥物管理局(FDA) 批准了TRAUMAGEL上市,這是一種突破性的植物來源止血凝膠,旨在幫助急救醫療團隊、創傷中心和一線救援人員處理核准至重度出血病例。
慢性傷口發生率增加
由於全球慢性傷口發生率不斷上升,水凝膠敷料市場正在擴張。隨著糖尿病、肥胖和血管疾病負擔的加重,糖尿病足潰瘍、靜脈性腿部潰瘍和壓瘡的發生率也不斷增加。根據國際糖尿病聯盟(IDF)最新發布的《糖尿病地圖集》(2025),20至79歲成年人中,11.1%(九分之一)患有糖尿病,其中超過40%的人並不知曉自己已被確診。患者越來越需要能夠同時提供保濕、止痛和預防感染的創傷護理產品,而水凝膠敷料恰好能夠有效滿足這些需求。醫療專業人員也擴大使用此類產品來促進傷口癒合,減輕患者的不適感。世界人口正在老化,老年患者的傷口癒合速度往往較慢,更容易出現難以治療的慢性傷口。這種人口結構的改變也正在推動市場需求。此外,文明病的增加以及醫院感染導致的傷口問題持續存在,也推動了水凝膠敷料市場的成長。隨著人們對慢性創傷護理管理的認知不斷提高,水凝膠敷料在臨床應用中也越來越廣泛。
技術進步與產品創新
隨著技術創新和產品開發的不斷推進,水凝膠敷料市場正經歷強勁成長。製造商正在研發新一代水凝膠敷料,以提高其吸收性、抗菌性和生物相容性。這些改進有助於改善創傷治療效果,同時最大限度地降低感染風險。各公司正對研發進行長期投資,以開發出方便用戶使用、經久耐用且適用於各種傷口類型的產品。智慧材料和生物活性物質的融合,為更高效、更有針對性的癒合過程開闢了可能性,使水凝膠敷料市場前景光明。醫療服務提供者和醫療設備製造商之間的合作正在加速產品檢驗和臨床試驗,從而促進其應用。監管部門的核准支持了新型水凝膠敷料的快速商業化,而市場競爭則推動了產品開發的持續改進。隨著科技的快速發展,新產品不斷湧現,更能滿足患者和醫療系統的需求,水凝膠敷料市場也隨之加速成長。 2024年,由迪帕·戈什(Deepa Ghosh)領導的莫哈利奈米科學與技術研究所(INST)的研究團隊開發出一種突破性的自主型敷料,用於治療難治性傷口。這種敷料具有抗菌作用,能夠促進創傷治療,對於糖尿病足潰瘍患者來說,是一種極具吸引力的多功能解決方案。為了應對這些挑戰,研究人員開發了一種創新的敷料,它由兩種成分組成:一種是由水凝膠微粒製成的電活性粉末,可直接塗抹於傷口;另一種是用於覆蓋傷口的電活性PVDF(聚二氟亞乙烯)膜。
人們越來越關注患者舒適度和成本效益高的照護。
水凝膠敷料市場的主要趨勢之一是醫療專業人員日益關注患者的舒適度和傷口管理的經濟高效解決方案。傳統敷料通常會引起疼痛,增加更換頻率,並延長癒合期,而水凝膠敷料可透過提供濕潤的癒合環境和減少更換頻率來最大限度地減輕疼痛。患者正在尋求能夠減輕疼痛並加快康復的治療方法,而水凝膠敷料能夠有效地滿足這一需求。此外,慢性創傷護理的成本給醫院和保險公司帶來了經濟壓力,促使醫療保健系統更加重視降低成本和提高效率。水凝膠敷料可透過最大限度地降低感染風險、縮短住院時間和控制併發症來降低整體治療成本。居家醫療的興起也推動了這一趨勢,使使用水凝膠敷料進行傷口護理對患者而言更加便利和經濟。水凝膠敷料兼具臨床療效和經濟效益,正被擴大應用於各種醫療保健機構。 IMARC Group預測,2025年至2033年全球創傷護理市場將以4.28%的複合年成長率成長。
The global hydrogel dressing market size was valued at USD 496.9 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 736.3 Million by 2034, exhibiting a CAGR of 4.33% from 2026-2034. North America currently dominates the market, holding a market share of 43.5% in 2025. At present, diabetic foot ulcers, venous leg ulcers, and pressure sores are on the rise with the burden of diabetes, obesity, and vascular disorders. Moreover, technological innovations and product development are constantly revolutionizing hydrogel formulations. Furthermore, heightened focus of healthcare professionals on patient comfort and budget-friendly solutions for wound management is expanding the hydrogel dressing market share.
The hydrogel dressing market is witnessing consistent growth as healthcare professionals are progressively embracing innovative wound care options. Demand is increasing because of the higher frequency of chronic wounds, burns, diabetic ulcers, and pressure sores, necessitating more effective and patient-centered treatments. The market is growing as hydrogel dressings provide advantages like sustaining a moist wound condition, alleviating pain, and enhancing quicker healing. The sector is experiencing technological progress as producers are creating groundbreaking items with better absorption, antimicrobial features, and superior biocompatibility. Businesses are persistently allocating funds to research and development, and partnerships with healthcare organizations are fostering product innovation. The market is reaping the rewards of heightened awareness regarding advanced wound care treatments, particularly in developing nations where healthcare systems are enhancing.
The United States hydrogel dressing market is experiencing consistent growth as demand for advanced wound care products is increasing across hospitals, clinics, and home healthcare settings. The market is benefiting from a rising prevalence of chronic conditions such as diabetes and obesity, which are leading to higher incidences of diabetic foot ulcers and pressure sores. Healthcare providers are increasingly adopting hydrogel dressings as these products are maintaining a moist wound environment, supporting faster healing, and improving patient comfort. The industry is witnessing continuous innovation as manufacturers are introducing hydrogel dressings with enhanced antimicrobial properties, better absorption capacity, and greater ease of application. Research and development (R&D) activities are expanding, while strategic collaborations between medical device companies and healthcare institutions are encouraging product advancements. The market is also strengthening as awareness of the benefits of advanced wound care solutions is growing among both healthcare professionals and patients. In 2024, The U.S. Food and Drug Administration authorized TRAUMAGEL, a revolutionary plant-based hemostatic gel Created to assist EMS teams, trauma centers, and 1st responders to manage moderate to severe bleeding cases.
Increased Incidence of Chronic Wounds
The market for hydrogel dressing is growing with the increasing incidence of chronic wounds across the world. Diabetic foot ulcers, venous leg ulcers, and pressure sores are on the rise with the burden of diabetes, obesity, and vascular disorders. The most recent International Diabetes Federation (IDF) Diabetes Atlas (2025) indicates that 11.1%, equivalent to 1 in 9 of adults (ages 20-79) are affected by diabetes, with more than 40% unaware of their diagnosis. Patients are demanding wound care products that are offering moisture balance, pain relief, and infection prevention, which hydrogel dressings are offering effectively. Healthcare practitioners are increasingly prescribing hydrogel dressings since these products are speeding up healing and reducing patient discomfort. The population of the world is aging, and older patients are more susceptible to having slow-healing and often resistant chronic wounds. This demographic change is also boosting market demand. Moreover, lifestyle conditions are increasing and hospital-acquired wounds are continuing, thus contributing to the hydrogel dressing market growth. With rising awareness about chronic wound care management, hydrogel dressings are increasingly being accepted in wider clinical circles.
Technological Advancements and Product Innovation
The market is experiencing robust growth with technological innovations and product development constantly revolutionizing hydrogel dressings. The manufacturers are creating next-generation hydrogel dressings with enhanced absorption, antimicrobial properties, and increased biocompatibility. These are facilitating better wound healing results with minimal risks of infection. Companies are making a long-term investment in research and development to create products that are convenient to use, long-lasting, and compatible with various wound types. Smart material and bioactive compound integration is opening opportunities for more efficient and targeted healing processes, thereby offering a favorable hydrogel dressing market outlook. Partnerships between healthcare providers and medical device companies are fostering product validation and clinical trials, which in turn is driving adoption. Regulatory approvals are helping to quickly commercialize new hydrogel dressings, and competition in the market is promoting ongoing product development improvements. As technology continues to advance at a breakneck pace, the market for hydrogel dressings is picking up speed as new products are better addressing both patient and healthcare system demands. In 2024, A team of researchers headed by Deepa Ghosh at the Institute of Nano Science and Technology (INST) in Mohali has developed a groundbreaking self-sustaining dressing aid for persistent wounds. This dressing possesses antibacterial properties and can enhance wound healing, presenting a compelling all-in-one option for those with diabetic foot ulcers. To tackle these deficiencies, the researchers created an innovative dressing aid that comprises two elements: an electroactive powder constructed from hydrogel microparticles for direct application on the wound, and an electroactive PVDF (polyvinylidene fluoride) membrane designed to cover the wound.
Increased Emphasis on Patient Comfort and Cost-Efficient Care
One of the major hydrogel dressing market trends includes the heightened focus of healthcare professionals on patient comfort and budget-friendly solutions for wound management. Conventional dressings are actually causing pain, more frequent changes, and longer healing times, but hydrogel dressings are minimizing pain by providing a moist healing environment and fewer changes. Patients are demanding treatments that are reducing pain and allowing for faster recovery, which hydrogel dressings are effectively fulfilling. Healthcare systems are also focusing on cost-cutting and efficiency, as the cost of chronic wound care is causing financial pressures on hospitals and insurers. Hydrogel dressings are lowering the cost of treatment overall by minimizing the risk of infection, reducing hospital stays, and limiting complications. The trend towards home healthcare is reaffirming this tendency, with patients treated for wounds with hydrogel dressings being able to do so more conveniently and cheaply. Being both clinically effective and economically efficient, hydrogel dressings are increasingly being adopted across various care environments. IMARC Group predicts that the global wound care market is expected to exhibit a growth rate (CAGR) of 4.28% during 2025-2033.
Amorphous hydrogel stands as the largest component in 2025, holding 48.7% of the market. It offers several meaningful advantages in wound care, and thus they are a meaningful option in the advanced dressing category. Hydrogels are made up of free-flowing, viscous preparations that are directly applied to wounds and covered by secondary dressings, and are providing flexibility and conformity to various wound types. One major advantage is moisture donation since amorphous hydrogels are rehydrating dry and necrotic tissue, facilitating autolytic debridement and speeding up healing of wounds. This characteristic is rendering them extremely appropriate for exudate minimal wounds, burns, and dry ulcers. They have another benefit, which is pain relief, as the moisturizing effect is calming wound beds and suppressing pain, a fact particularly significant in chronic or painful wound patients. Amorphous hydrogels are also offering versatility since they can be applied to irregular shapes of wounds and cavities where sheet or impregnated hydrogel dressings would not be feasible.
Synthetic stand as the largest component in 2025, holding 60.5% of the market. Synthetic hydrogel dressings are presenting unique advantages that are making them progressively important in advanced wound care management. Synthetic hydrogel variants are designed to offer greater consistency, strength, and functionality compared to hydrogels of natural origin, thus providing more consistent clinical results. One of the primary advantages is controlled composition and quality. Since they are produced with synthetic polymers, such dressings are being preserved in uniform structure and stable performance. This stability is minimizing variability in healing results in wounds, which is particularly valuable for hospital and clinical use. A second significant benefit is increased durability and stability. Synthetic hydrogels are now withstanding degradation for longer durations, meaning they can stay functional on wounds without having to be changed often. This characteristic is reducing the workload for healthcare workers and patients by limiting dressing replacement.
Diabetic foot ulcer leads the market as it is one of the most serious diabetes complications, and it necessitates expert wound care techniques to avert infection, amputation, and disability. Hydrogel dressings are being increasingly acknowledged as a viable solution in addressing the multifaceted needs of such wounds because of their distinct characteristics. One of the most important requirements is moist wound healing since diabetic ulcers may be dry or necrotic. Hydrogel dressings are delivering much-needed hydration to rehydrate devitalized tissue, aiding autolytic debridement, and establishing a milieu that facilitates quicker granulation and epithelialization. Pain management is yet another important requirement. Diabetic foot ulcer patients are often in great pain, and hydrogel dressings are calming wound beds, decreasing pain, and causing less trauma upon dressing change because they are not adherent.
Hospital leads the market with 56.5% of market share in 2025. Hospitals are insisting on hydrogel dressings as a standard part of their advanced wound care regimes because these items are meeting severe needs in the treatment of both chronic and acute wounds. The increasing pressure of pressure ulcers, surgical wounds, diabetic foot ulcers, and burns is leading to a need for dressings that are promoting effective healing, patient comfort, and cost-effectiveness. One of the key requisites is creating a moist wound environment, which is scientifically established to increase the healing process. Hydrogel dressings are delivering maximum hydration, facilitating autolytic debridement, and promoting tissue regeneration and are, therefore, ideal for wounds with low to moderate exudate. Hospitals are also focusing on pain minimization and patient comfort. As hydrogel dressings are soothing and non-adherent, they are reducing trauma at dressing changes and overall discomfort, enhancing patient recovery experiences.
In 2025, North America accounted for the largest market share of 43.5%. The hydrogel dressing sector in the region is experiencing steady expansion as healthcare providers are increasingly adopting advanced wound care solutions to manage a rising number of chronic and acute wounds. The prevalence of diabetes, obesity, and pressure ulcers is growing, and these conditions are driving the demand for wound dressings that are maintaining moisture balance, accelerating healing, and reducing patient discomfort. Hospitals, outpatient facilities, and home healthcare providers are widely incorporating hydrogel dressings as part of standard wound management protocols. The market is also witnessing significant innovation as manufacturers are developing synthetic and bioengineered hydrogels with improved durability, antimicrobial capabilities, and drug delivery features. Research collaborations between medical device companies and healthcare institutions are supporting clinical studies, while regulatory approvals are facilitating the commercialization of novel products. The aging population across North America is further increasing the incidence of chronic wounds, creating consistent demand for effective wound care options.
UNITED STATES HYDROGEL DRESSING MARKET ANALYSIS
The United States market, holding a share of 88.90%, is primarily driven by the growing number of surgical procedures, which necessitate efficient and sterile wound management solutions. In line with this, the expansion of outpatient services and ambulatory surgical centers, which favor advanced dressings for quicker recovery, is impelling the market. According to the Ambulatory Surgical Center Services Status Report, in 2023, approximately 6,300 ASCs treated 3.4 million Medicare fee-for-service beneficiaries, resulting in total spending of USD 6.8 Billion. Procedure volume per beneficiary rose by 5.7% in 2023, with an average annual growth of 0.6% from 2018 to 2022. The increasing preference for moisture-retentive and non-adherent materials among patients and clinicians is further propelling market growth. Furthermore, the heightened demand for home healthcare products in the U.S., highlighting the ongoing shift toward self-managed wound care, is strengthening market demand. Similarly, favorable reimbursement policies for advanced wound treatments are supporting the adoption of these treatments in medical settings. The increasing focus on infection prevention in chronic wound management is driving the use of hydrogels. Besides this, strategic alliances between manufacturers and healthcare providers are expanding product accessibility and facilitating clinical integration.
EUROPE HYDROGEL DRESSING MARKET ANALYSIS
The European market is experiencing growth due to the rising incidence of chronic wounds associated with aging populations and lifestyle-related diseases. An industry report states that over 10 million people in Europe suffer from skin ulcers annually, costing healthcare systems more than EUR 4 Billion. Over 60% of cases occur in individuals over 65, often linked to chronic conditions like diabetes, vascular issues, heart disease, and obesity. In line with this, the growing number of pressure ulcers in long-term care settings is driving demand for advanced moisture-retaining dressings. Similarly, strong regulatory frameworks supporting clinical safety and efficacy are fostering product innovation and encouraging new entrants. The expansion of government-backed research programs and clinical trials is accelerating advancements in hydrogel formulation. Additionally, the rapid integration of hydrogel dressings into national health service protocols, particularly in countries with universal healthcare, is improving procurement and utilization. The growing emphasis on digital wound monitoring and telemedicine platforms, which increase access to specialized treatments, is stimulating market appeal. Moreover, rising healthcare investments across EU nations, supporting infrastructure upgrades, and the availability of advanced wound care products in both hospital and home care settings are impacting market trends.
ASIA PACIFIC HYDROGEL DRESSING MARKET ANALYSIS
The Asia Pacific market is largely propelled by the rising prevalence of diabetes and chronic wounds, particularly in densely populated countries. According to the National Family Health Survey (2019-2021), the prevalence of diabetes among Indian adults stands at 6.5%. An expanded analysis of the same data, including both diagnosed and undiagnosed individuals, suggests the actual prevalence may be around 16.1%, reflecting broader awareness and detection efforts. In addition to this, improved access to healthcare in rural areas is supporting the adoption of advanced wound care products across wider demographics. Similarly, significant investments in healthcare infrastructure across India, China, and Southeast Asia are enabling broader availability of modern dressings in public and private hospitals. Furthermore, rising demand for non-invasive, cost-effective treatments among middle- and low-income patients is extending market acceptance. Apart from this, increased emphasis on home-based care solutions is encouraging the use of user-friendly hydrogel dressings across outpatient and chronic care scenarios.
LATIN AMERICA HYDROGEL DRESSING MARKET ANALYSIS
In Latin America, the market is growing due to the expansion of government-led healthcare modernization initiatives aimed at improving access to advanced wound care in underserved areas. Similarly, the increasing clinical awareness of moist wound healing techniques among medical professionals is driving the adoption of hydrogel-based solutions in hospitals and outpatient care settings. The rising burden of chronic conditions such as diabetes and peripheral vascular disease is further supporting the demand for effective and gentle wound care products. According to NCBI, around 16 million people in Brazil were diagnosed with diabetes mellitus in 2019. Furthermore, strategic collaborations between regional healthcare providers and global wound care manufacturers are enhancing distribution channels and ensuring greater availability of high-quality hydrogel dressings throughout both public and private healthcare systems.
MIDDLE EAST AND AFRICA HYDROGEL DRESSING MARKET ANALYSIS
The market in the Middle East and Africa is experiencing growth due to increased investment in healthcare infrastructure, particularly in high-income economies like the UAE and Saudi Arabia. As such, the Saudi Arabian government committed over USD 65 Billion to enhancing the nation's healthcare infrastructure, highlighting its focus on building a strong, resilient system to address the changing healthcare needs of its population. Furthermore, the rise of public-private healthcare partnerships is enhancing the distribution and availability of advanced wound care products. Similarly, targeted diabetes awareness and management programs are promoting timely treatment and preventative care. Moreover, the expansion of medical tourism, particularly in countries with advanced clinical capabilities, is encouraging the adoption of innovative, patient-friendly solutions, thereby providing an impetus to the market.
Market players in the hydrogel dressing industry are actively engaging in product innovation, strategic collaborations, and geographical expansion to strengthen their competitive positions. Companies are investing heavily in research and development to introduce advanced hydrogel dressings with enhanced absorption, antimicrobial properties, and drug delivery capabilities. Partnerships with hospitals, clinics, and research institutions are supporting clinical validation and accelerating adoption in healthcare settings. Leading firms are also focusing on mergers, acquisitions, and licensing agreements to expand product portfolios and enter new regional markets. As per the hydrogel dressing market forecasts, manufacturers are expected to improve distribution networks and emphasize patient-friendly, cost-effective solutions to address growing demand across hospitals, outpatient facilities, and home healthcare environments.